摘要
目的探讨万乃洛韦对带状疱疹的临床疗效。方法选择我科70例带状疱疹患者,按照随机数字表将其分为对照组(n=35)及观察组(n=35),前者应用阿昔洛韦,后者应用万乃洛韦;比较两组疗效及安全性。结果观察组临床总有效率为94.29%,高于对照组74.29%(P<0.05)。观察组不良反应发生率与对照组差异无统计学意义(P>0.05)。结论应用万乃洛韦治疗带状疱疹兼具有疗效及安全性。
Objective To explore the clinical efficacy of valacyclovir for herpes zoster. Methods 70 cases of patients with herpes zoster were randomly divided into two groups,the control group（n=35）and the observation group（n=35）. Former used acyclovir,latter used valacyclovir. The curative effect and safety of two groups were compared. Results The total effective rate of the observation group was 94.29%,which was significantly higher than the control group 74.29%（P〈0.05）. The adverse reaction rate of the observed group and the control group,P〈0.05. Conclusion Application of valaciclovir in treatment of herpes zoster has efficacy and safety.
出处
《中国卫生标准管理》
2016年第2期112-113,共2页
China Health Standard Management
